Evidence map›Paper›PMID 32578508›Full record

ArticleTechnology in cancer research & treatment

Clinical Efficacy of HiPorfin Photodynamic Therapy for Advanced Obstructive Esophageal Cancer.

Ruifang Zeng, Chen Liu, Libo Li, Xiaojun Cai, Run Chen, Zhiwen Li

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05174117 naunknown statusnot on this map

A Phase III Randomized Controlled Study of the Effect of Different Light Doses on Adverse Outcomes of Swallowing in Esophageal Cancer

TypeinterventionalSponsorThe First Affiliated Hospital of Henan University of Science and TechnologyRan2022 to 2023Enrolled57ConditionsEsophagus CancerArmssingle irradiation, Double irradiation
NCT05208775 naunknown statusnot on this map

A Phase III, Randomized, Controlled Study of Endoscopic Submucosal Dissection Versus Photodynamic Therapy for Early Esophageal Cancer

TypeinterventionalSponsorThe First Affiliated Hospital of Henan University of Science and TechnologyRan2022 to 2024Enrolled46ConditionsEsophageal Carcinoma in Situ AJCC V7ArmsPDT, ESD
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Activatable Photosensitizers: From Fundamental Principles to Advanced Designs.Angewandte Chemie (International ed. in English) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ruifang ZengCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.ORCID 0000-0001-6657-1330
Chen LiuThe First Department of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Libo LiCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Xiaojun CaiCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Run ChenCancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Zhiwen LiThe First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
TCM-Intigrated Cancer Center of Southern Medical University · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the clinical efficacy of HiPorfin photodynamic therapy for advanced esophageal cancer and evaluate its impact on survival.

methodsRetrospective analysis of 32 patients with advanced obstructive esophageal cancer at our institution from September 2013 to December 2016. HiPorfin was infused as the photosensitizer at a dose of 5 mg/kg, and after 48 hours, 630-nm laser irradiation was subsequently performed through an optical fiber that passed through the biopsy channel of a flexible endoscope.

resultsThe effectiveness rate was 78.1% (25/32), and the significant efficacy rate was 56.3% (18/32). The dysphagia score decreased from 3.43 ± 0.73 to 1.79 ± 0.53 (

conclusionPhotodynamic therapy is an effective method for advanced esophageal cancer. The side effects are mild, and the short-term effect is good, especially in the relief of dysphagia. Photodynamic therapy can prolong the survival of patients with advanced esophageal cancer, and the Karnofsky Performance Status score and previous radiation therapy have a significant effect on the overall survival.

Indexed as

AdultAgedEsophageal NeoplasmsFemaleFollow-Up StudiesHematoporphyrinsHumansMaleMiddle AgedPhotochemotherapyPhotosensitizing AgentsPrognosisRetrospective StudiesSurvival RateHematoporphyrinsPhotosensitizing Agentsclinical efficacyesophageal cancerobstructionphotodynamic therapysurvival

Identifiers

PMID32578508
PMCPMC7315671
OpenAlexW3037984939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.